These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 33445756)

  • 1. Anti-
    Martinez-Peinado N; Martori C; Cortes-Serra N; Sherman J; Rodriguez A; Gascon J; Alberola J; Pinazo MJ; Rodriguez-Cortes A; Alonso-Padilla J
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33445756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amaryllidaceae alkaloids with anti-Trypanosoma cruzi activity.
    Martinez-Peinado N; Cortes-Serra N; Torras-Claveria L; Pinazo MJ; Gascon J; Bastida J; Alonso-Padilla J
    Parasit Vectors; 2020 Jun; 13(1):299. PubMed ID: 32522289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amaryllidaceae plants: a potential natural resource for the treatment of Chagas disease.
    Martínez-Peinado N; Cortes-Serra N; Tallini LR; Pinazo MJ; Gascon J; Bastida J; Alonso-Padilla J
    Parasit Vectors; 2021 Jun; 14(1):337. PubMed ID: 34174959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of new potent hits against intracellular Trypanosoma cruzi by QSAR-based virtual screening.
    Melo-Filho CC; Braga RC; Muratov EN; Franco CH; Moraes CB; Freitas-Junior LH; Andrade CH
    Eur J Med Chem; 2019 Feb; 163():649-659. PubMed ID: 30562700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two analogues of fenarimol show curative activity in an experimental model of Chagas disease.
    Keenan M; Chaplin JH; Alexander PW; Abbott MJ; Best WM; Khong A; Botero A; Perez C; Cornwall S; Thompson RA; White KL; Shackleford DM; Koltun M; Chiu FC; Morizzi J; Ryan E; Campbell M; von Geldern TW; Scandale I; Chatelain E; Charman SA
    J Med Chem; 2013 Dec; 56(24):10158-70. PubMed ID: 24304150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of novel quinine analogs and evaluation of their effects on Trypanosoma cruzi.
    Ceole LF; Gandhi H; Villamizar LH; Soares MJ; O'Sullivan TP
    Future Med Chem; 2018 Feb; 10(4):391-408. PubMed ID: 29380636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indirubin derivatives are potent and selective anti-Trypanosoma cruzi agents.
    Efstathiou A; Meira CS; Gaboriaud-Kolar N; Bastos TM; Rocha VPC; Vougogiannopoulou K; Skaltsounis AL; Smirlis D; Soares MBP
    Virulence; 2018; 9(1):1658-1668. PubMed ID: 30387370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine Learning Models and Pathway Genome Data Base for Trypanosoma cruzi Drug Discovery.
    Ekins S; de Siqueira-Neto JL; McCall LI; Sarker M; Yadav M; Ponder EL; Kallel EA; Kellar D; Chen S; Arkin M; Bunin BA; McKerrow JH; Talcott C
    PLoS Negl Trop Dis; 2015; 9(6):e0003878. PubMed ID: 26114876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental models in Chagas disease: a review of the methodologies applied for screening compounds against Trypanosoma cruzi.
    Fonseca-Berzal C; Arán VJ; Escario JA; Gómez-Barrio A
    Parasitol Res; 2018 Nov; 117(11):3367-3380. PubMed ID: 30232605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death.
    da Silva EB; Oliveira E Silva DA; Oliveira AR; da Silva Mendes CH; Dos Santos TA; da Silva AC; de Castro MC; Ferreira RS; Moreira DR; Cardoso MV; de Simone CA; Pereira VR; Leite AC
    Eur J Med Chem; 2017 Apr; 130():39-50. PubMed ID: 28242550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of Strong 3-Nitro-2-Phenyl-
    Carey SM; O'Neill DM; Conner GB; Sherman J; Rodriguez A; D'Antonio EL
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death.
    Magalhaes Moreira DR; de Oliveira AD; Teixeira de Moraes Gomes PA; de Simone CA; Villela FS; Ferreira RS; da Silva AC; dos Santos TA; Brelaz de Castro MC; Pereira VR; Leite AC
    Eur J Med Chem; 2014 Mar; 75():467-78. PubMed ID: 24561675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel drug design for Chagas disease via targeting Trypanosoma cruzi tubulin: Homology modeling and binding pocket prediction on Trypanosoma cruzi tubulin polymerization inhibition by naphthoquinone derivatives.
    Ogindo CO; Khraiwesh MH; George M; Brandy Y; Brandy N; Gugssa A; Ashraf M; Abbas M; Southerland WM; Lee CM; Bakare O; Fang Y
    Bioorg Med Chem; 2016 Aug; 24(16):3849-55. PubMed ID: 27345756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammea type coumarins isolated from Calophyllum brasiliense induced apoptotic cell death of Trypanosoma cruzi through mitochondrial dysfunction, ROS production and cell cycle alterations.
    Rodríguez-Hernández KD; Martínez I; Reyes-Chilpa R; Espinoza B
    Bioorg Chem; 2020 Jul; 100():103894. PubMed ID: 32388434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel N,N-di-alkylnaphthoimidazolium derivative of β-lapachone impaired Trypanosoma cruzi mitochondrial electron transport system.
    Bombaça ACS; Silva LA; Chaves OA; da Silva LS; Barbosa JMC; da Silva AM; Ferreira ABB; Menna-Barreto RFS
    Biomed Pharmacother; 2021 Mar; 135():111186. PubMed ID: 33395606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo activity of the chloroaryl-substituted imidazole viniconazole against Trypanosoma cruzi.
    Silva CF; Batista Dda G; Batista MM; Lionel J; Hammer ER; Brun R; Soeiro Mde N
    Parasitology; 2014 Mar; 141(3):367-73. PubMed ID: 24553079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of novel
    Espinoza-Chávez RM; Oliveira Rezende Júnior C; de Souza ML; Pauli I; Valli M; Gomes Ferreira LL; Chelucci RC; Michelan-Duarte S; Krogh R; Romualdo da Silva FB; Cruz FC; de Oliveira AS; Andricopulo AD; Dias LC
    Future Med Chem; 2024 Feb; 16(3):253-269. PubMed ID: 38193294
    [No Abstract]   [Full Text] [Related]  

  • 19. Antitrypanosomal Activity of Sterol 14α-Demethylase (CYP51) Inhibitors VNI and VFV in the Swiss Mouse Models of Chagas Disease Induced by the Trypanosoma cruzi Y Strain.
    Guedes-da-Silva FH; Batista DG; Da Silva CF; De Araújo JS; Pavão BP; Simões-Silva MR; Batista MM; Demarque KC; Moreira OC; Britto C; Lepesheva GI; Soeiro MN
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the structure-activity relationships of N'-[(5-nitrofuran-2-yl) methylene] substituted hydrazides against Trypanosoma cruzi to design novel active compounds.
    Palace-Berl F; Pasqualoto KFM; Zingales B; Moraes CB; Bury M; Franco CH; da Silva Neto AL; Murayama JS; Nunes SL; Silva MN; Tavares LC
    Eur J Med Chem; 2018 Jan; 144():29-40. PubMed ID: 29247858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.